Cytokine signature of inflammation mediated by autoreactive Th-cells, in calf muscle of claudicating patients with Fontaine stage II peripheral artery disease

• Published in: Translational research : the journal of laboratory and clinical medicine Vol. 228; pp. 94 - 108
• Main Authors: Casale, George P., Thompson, Jonathan R., Carpenter, Lauren C., Kim, Julian, Lackner, Timothy J., Mietus, Constance J., Ha, Duy M., Myers, Sara A., Brunette, Katyarina E., Li, Shuai, Shields, Christina, Willcockson, Gregory, Pipinos, Iraklis I.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-02-2021
• Subjects: Cytokines - metabolism; Female; Humans; Inflammation - metabolism; Intermittent Claudication - metabolism; Male; Middle Aged; Muscle, Skeletal - metabolism; Peripheral Arterial Disease - metabolism; T-Lymphocytes, Helper-Inducer - metabolism; DTT; vSMC; dNTPs; COD; PWD; WIQ; QoL; TRIS
• ISSN: 1931-5244; 1878-1810
• DOI: 10.1016/j.trsl.2020.08.008

Peripheral artery disease (PAD), a severe atherosclerotic condition primarily of the elderly, afflicts 200 million individuals, worldwide, and is associated with lower extremity myopathy. Circulating markers of inflammation have been linked to risk and severity of PAD but the contribution of local inflammation to myopathy remains unknown. We evaluated, by ELISA, calf muscle of PAD patients (N = 23) and control subjects (N = 18) for local expression of inflammatory cytokines including Granulocyte/Monocyte Colony-Stimulating Factor (GM-CSF), Interleukin 17A (IL-17A), Interferon ϒ (IFN-ϒ), tumor necrosis factor α (TNF-α), and Interleukin 6 (IL-6). One or more of these cytokines were expressed in nineteen patients and 2 controls and coordinated expression of GM-CSF, IL-17A, IFN-ϒ, and TNF-α, a signature of activated, MHC Class II dependent autoreactive Th-cells, was unique to 11 patients. GM-CSF is the central driver of tissue-damaging myeloid macrophages. Patients with this cytokine signature had a shorter (P= 0.017) Claudication Onset Distance (17 m) compared with patients lacking the signature (102 m). Transforming Growth Factor β1 (TGFβ1) and Chemokine Ligand 5 (CCL5) were expressed coordinately in all PAD and control muscles, independently of GM-CSF, IL-17A, IFN-ϒ, TNF-α, or IL-6. TGFβ1 and CCL5 and their gene transcripts were increased in PAD muscle, consistent with increased age-associated inflammation in these patients. Serum cytokines were not informative of muscle cytokine expression. We have identified a cytokine profile of autoimmune inflammation in calf muscles of a significant proportion of claudicating PAD patients, in association with decreased limb function, and a second independent profile consistent with increased “inflammaging” in all PAD patients.